Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy.

Ptaszynska-Kopczynska K, Szpakowicz A, Marcinkiewicz-Siemion M, Lisowska A, Waszkiewicz E, Witkowski M, Jakim P, Galar B, Musial WJ, KamiƄski KA.

Arch Med Sci. 2017 Aug;13(5):1069-1077. doi: 10.5114/aoms.2016.58635. Epub 2016 Mar 17.

2.

Modalities of ventricular pacing for cardiac resynchronization therapy in patients with heart failure: a meta-analysis and systematic review.

Chen A, Chen X, Shen Y, Li W.

Arch Med Sci. 2017 Aug;13(5):1006-1017. doi: 10.5114/aoms.2017.65660. Epub 2017 Jan 31. Review.

3.

Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy: Clinical Management and Outcome.

Boriani G, Battistini P, Diemberger I, Ziacchi M, Valzania C, Martignani C, Biffi M.

J Atr Fibrillation. 2013 Feb 12;5(5):748. doi: 10.4022/jafib.748. eCollection 2013 Feb-Mar. Review.

4.

Differential Effects of Left Ventricular Pacing Sites on Regional Contraction Patterns and Global Performance.

Pinsky MR, Kim HK, Zenker S, Johnson L, Shroff S.

J Cardiothorac Vasc Anesth. 2016 Jun;30(3):709-15. doi: 10.1053/j.jvca.2016.01.024. Epub 2016 Jan 19.

5.

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.

Dewhurst MJ, Linker NJ.

Arrhythm Electrophysiol Rev. 2014 May;3(1):9-14. doi: 10.15420/aer.2011.3.1.9. Epub 2014 May 30.

6.
7.

Atrial synchronous left ventricular only pacing with VDD pacemaker system - a cost effective alternative to conventional cardiac resynchronization therapy.

Gopi A, Sundar G, Yelagudri S, Lalukota K, Sridevi C, Narasimhan C.

Indian Heart J. 2014 Nov-Dec;66(6):612-6. doi: 10.1016/j.ihj.2014.10.398. Epub 2014 Dec 22.

8.

Device therapies: new indications and future directions.

Kumar P, Schwartz JD.

Curr Cardiol Rev. 2015;11(1):33-41. Review.

9.

British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Whinnett ZI, Sohaib SM, Jones S, Kyriacou A, March K, Coady E, Mayet J, Hughes AD, Frenneaux M, Francis DP; BRAVO Investigators.

BMC Cardiovasc Disord. 2014 Apr 3;14:42. doi: 10.1186/1471-2261-14-42.

10.

Sites of latest mechanical activation as assessed by SPECT myocardial perfusion imaging in ischemic and dilated cardiomyopathy patients with LBBB.

Lin X, Xu H, Zhao X, Chen J.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1232-9. doi: 10.1007/s00259-014-2718-6. Epub 2014 Feb 28.

11.

Potential pro-arrhythmic effect of cardiac resynchronization therapy.

Tayeh O, Farouk W, Elazab A, Khald H, Curnis A.

J Saudi Heart Assoc. 2013 Jul;25(3):181-9. doi: 10.1016/j.jsha.2013.05.002. Epub 2013 May 30.

12.

Relationship of electro-mechanical remodeling to survival rates after cardiac resynchronization therapy.

Kiani J, Agarwal SK, Kamireddy S, Adelstein E, Saba S.

Tex Heart Inst J. 2013;40(3):268-73.

13.

Predictors of cardiac resynchronization therapy response: the pivotal role of electrocardiogram.

Al Hebaishi YS, Al Shehri HZ, Al Moghairi AM.

ScientificWorldJournal. 2013;2013:837086. doi: 10.1155/2013/837086. Epub 2013 Mar 20. Review.

14.

Devices in the management of advanced, chronic heart failure.

Abraham WT, Smith SA.

Nat Rev Cardiol. 2013 Feb;10(2):98-110. doi: 10.1038/nrcardio.2012.178. Epub 2012 Dec 11. Review.

15.

Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis of randomized controlled trials.

Tu R, Zhong G, Zeng Z, Wu W, Wu H, Cao X, Aung LH.

Cardiovasc Drugs Ther. 2011 Aug;25(4):331-40. doi: 10.1007/s10557-011-6313-9. Review.

16.

SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony.

Chen J, Garcia EV, Bax JJ, Iskandrian AE, Borges-Neto S, Soman P.

J Nucl Cardiol. 2011 Aug;18(4):685-94. doi: 10.1007/s12350-011-9392-x. Review.

17.

The use of nuclear imaging for cardiac resynchronization therapy.

Chen J, Boogers MJ, Bax JJ, Soman P, Garcia EV.

Curr Cardiol Rep. 2010 Mar;12(2):185-91. doi: 10.1007/s11886-010-0086-9. Review. Erratum in: Curr Cardiol Rep. 2010 Sep;12(5):446. Boogers, Mark M [corrected to Boogers, Mark J].

18.

Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement.

Ailawadi G, Lapar DJ, Swenson BR, Maxwell CD, Girotti ME, Bergin JD, Kern JA, Dimarco JP, Mahapatra S.

Heart Rhythm. 2010 May;7(5):619-25. doi: 10.1016/j.hrthm.2010.01.014. Epub 2010 Jan 20.

19.

Patient assessment for cardiac resynchronization therapy: Past, present and future of imaging techniques.

Auger D, Ducharme A, Harel F, Thibault B, O'Meara E.

Can J Cardiol. 2010 Jan;26(1):27-34. Review.

20.

SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.

Stein KM, Ellenbogen KA, Gold MR, Lemke B, Lozano IF, Mittal S, Spinale FG, Van Eyk JE, Waggoner AD, Meyer TE.

Pacing Clin Electrophysiol. 2010 Jan;33(1):54-63. doi: 10.1111/j.1540-8159.2009.02581.x. Epub 2009 Oct 10.

Supplemental Content

Support Center